title: The History and Challenges of Blood Donor Screening in China.
abstract: Since the establishment of People's Republic of China in 1949, the Chinese government has encountered several catastrophes related to transfusion transmitted diseases. The government's increasing attention to blood safety has prompted the initiation of a series of policies and measures that have enhanced the level of safety for the blood supply and met the basic clinical demands of blood for 1.3 billion people in the country. Blood donation screening strategies in China predominantly comprise donor screening and donor testing. Donor screening includes selection of low-risk blood donors by the use of a donor history questionnaire, predonation physical examination, and initial rapid donor testing. Donor testing includes direct pathogen detection and serology tests. The year 1998 marked the most transformative change in blood donor selection and screening policies in China. Before 1998, paid donation was the predominant mode of blood donation. Donor screening and donor testing were conducted before donation, and only those who were eligible were allowed to donate. To ensure the safety of blood, donor testing was performed again after donation. After the implementation of the Blood Donation Law in 1998, to promote voluntary and unpaid donation, predonation donor testing was eliminated to reduce the amount of waiting time and to provide a more convenient donation experience for blood donors. However, it is the national requirement that donated blood should undergo 2 rounds of testing using different equipment or reagents, conducted by different personnel. Donor selection has transitioned from paid donation and obligatory donation to voluntary donation with fixed volunteer groups, as the latter mode of donation provides the lowest risks. Donations are currently screened for syphilis, hepatitis C virus, HIV, and hepatitis B virus (HBV). Units, previously typed only for ABO, are now routinely tested for both ABO and Rh(D). Innovations in testing technologies and methods have also brought changes to screening parameters. For instance, screening for HBV pathogens evolved from the early use of hemagglutination method to the later use of radioimmunoassay, independent enzyme-linked immunosorbent assay, and now the widespread application of nucleic acid test (NAT). Since 2010, the Chinese government has established NAT capacity in several blood centers; and in 2015, the government invested 900 million RMB on the nationwide expansion of NAT. Although the Chinese government has worked to enhance blood safety, many challenges remain. Concern exists for rising rates of HIV infection. The existence of occult HBV infection and the transmission of emerging blood-borne diseases continue to challenge the safety of the blood supply.
authors.affiliation: Institute of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical College, Chengdu, China.
authors.forename: Ling
authors.initials: L
authors.lastname: Li
authors.affiliation: Cooper Medical School of Rowan University, Camden, NJ, United States.
authors.forename: Ka Yi
authors.initials: KY
authors.lastname: Li
authors.affiliation: Institute of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical College, Chengdu, China.
authors.forename: Ke
authors.initials: K
authors.lastname: Yan
authors.affiliation: Institute of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical College, Chengdu, China.
authors.forename: Guojin
authors.initials: G
authors.lastname: Ou
authors.affiliation: Institute of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical College, Chengdu, China.
authors.forename: Wenhui
authors.initials: W
authors.lastname: Li
authors.affiliation: Institute of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical College, Chengdu, China.
authors.forename: Jue
authors.initials: J
authors.lastname: Wang
authors.affiliation: Institute of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical College, Chengdu, China.
authors.forename: Ning
authors.initials: N
authors.lastname: Song
authors.affiliation: Institute of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical College, Chengdu, China.
authors.forename: Li
authors.initials: L
authors.lastname: Tian
authors.affiliation: Institute of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical College, Chengdu, China.
authors.forename: Xin
authors.initials: X
authors.lastname: Ji
authors.affiliation: Institute of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical College, Chengdu, China.
authors.forename: Yongjun
authors.initials: Y
authors.lastname: Chen
authors.affiliation: Liaoning Dalian Blood Center, Dalian, China. Electronic address: liangxiaohua1968@126.com.
authors.forename: Xiaohua
authors.initials: X
authors.lastname: Liang
authors.affiliation: Institute of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical College, Chengdu, China. Electronic address: liuz@ibt.pumc.edu.cn.
authors.forename: Zhong
authors.initials: Z
authors.lastname: Liu
authors.affiliation: Institute of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical College, Chengdu, China; Bloodworks, Seattle, WA, United States.
authors.forename: Yanyun
authors.initials: Y
authors.lastname: Wu
mesh_terms: D001782:Blood Donors / Q000331:legislation & jurisprudence / Q000600:supply & distribution; D058731:Blood Safety / Q000266:history / Q000592:standards; D002681:China; D003140:Communicable Disease Control / Q000266:history / Q000458:organization & administration / Q000592:standards; D046148:Donor Selection / Q000266:history / Q000379:methods / Q000458:organization & administration / Q000592:standards; D049673:History, 20th Century; D049674:History, 21st Century; D006801:Humans; D007883:Legislation, Medical / Q000266:history; D008403:Mass Screening / Q000266:history / Q000379:methods / Q000458:organization & administration / Q000592:standards
keywords: Blood donor screening; China; History; Strategies; Transfusion